Agree. MedAdvisor seems to have weathered the general negative...

Agree. MedAdvisor seems to have weathered the general negative market sentiment the best.

Looking back at the peer comparison from last month, most have dropped with their HY figures and been impacted by this week's perceived Corona scare.

January 31 2020


February 28 2020

• MC based on yesterday's close
• RAP recently raised $5M. They will need another CR next quarter
• PCK revenue up 52% but total revenue is only worth a years salary
• ALC continues to perform but still below MDR

I'm seeing a trend where MedAdvisor Management aren't ones to release 'pump news', but rather include bread crumbs in the mandatory financial reports. I have not seen the linkage between HMS and DHCRC before.

https://www.digitalhealthcrc.com/hms-data-sets/

This is an AU Gov initiative, yet HMS as stated in this announcement, is the largest private funder.
They have picked the right horse or perhaps the horse picked them.

"This represents a significant opportunity to further expand the impacted patient network in the US, as well as participate domestically in the Digital Health CRC, in which HMS is the largest private contributor of funding."

Asia
It looks like the Zuellig JV with both MedExpress and Klinify has again been pushed out, this time to H2 2020, which is disappointing. But in saying that I work in Product Engineering and find most 'go live' dates that involve third parties are rarely delivered on time. Let's hope the the revenue is worth the wait.

UK
Encouraging that Day Lewis are choosing to take more than the custom branded app and looking to integrate PlusOne into their pharmacies as well. I recall reading there are less dispense vendors in the UK than in AU, so once integration is complete here, any new entry with a different chain will be cheaper again. Revenue to start next quarter. Just imagine if they sign a Boots, Lloyds or Tesco!

US
This is the money shot. HMS providing $11M in cash which saw Regal come in with $5M is a lot of runway (still $16M in the kitty). Only two Health Programs announced so far which I've guessed one is for BMS (Bristol Myers Squibb) is like putting a little toe in the pool. They do over 30 Health Programs in AU. Many more pharma groups to target with Adheris as our major partner. I also hope the HMS Eliza opportunity is still real.

AU
They've stated they have 3 of the largest pharmacy groups on long term contracts. The fourth is API who is in a perceived stoush with Sigma, so may be playing a game of chess with suppliers, hence not choosing to re-sign at the moment. eScripts is the new target locally. If they can position themselves as the platform of choice, then there may be an influx of users once the regulatory conditions settle and the market knows what providers are available.

Execs
Two excellent appointments with Jeffrey Sherman (HMS) and Chris Ridd from XRO. HMS already present in the AU Healthcare market as per the announcement and Chris seems an excellent fit with a strong background in growing small SaaS companies.

Lots to like in the coming months and in 2020, so I used this market overreaction to buy more this week - my first buys since consolidation. I predict in a few months ~$100M MC and 40c will look very cheap.

Also why I like MedAdvisor, is the level silence on this forum. The other entities above have 10s of thousands of posts and monthly visits. There seems to be an inverse rule on HC, those companies with lots of 'chatter' don't always correlate to a rising share price, despite regularly hitting the most discussed.